Current treatment and recent progress in gastric cancer
SS Joshi, BD Badgwell - CA: a cancer journal for clinicians, 2021 - Wiley Online Library
Gastric cancer is not a top‐10 malignancy in the United States but represents one of the
most common causes of cancer death worldwide. Biological differences between tumors …
most common causes of cancer death worldwide. Biological differences between tumors …
Microsatellite instability: a review of what the oncologist should know
K Li, H Luo, L Huang, H Luo, X Zhu - Cancer cell international, 2020 - Springer
The patients with high microsatellite instability (MSI-H)/mismatch repair deficient (dMMR)
tumors recently have been reported that can benefit from immunotherapy, and MSI can be …
tumors recently have been reported that can benefit from immunotherapy, and MSI can be …
Assessment of pembrolizumab therapy for the treatment of microsatellite instability–high gastric or gastroesophageal junction cancer among patients in the KEYNOTE …
J Chao, CS Fuchs, K Shitara, J Tabernero… - JAMA …, 2021 - jamanetwork.com
Importance Immunotherapy has been associated with improved outcomes among patients
who have received previous treatment for microsatellite instability–high (MSI-H) tumors …
who have received previous treatment for microsatellite instability–high (MSI-H) tumors …
Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in localized deficient mismatch repair/microsatellite instability–high gastric or esophagogastric …
PURPOSE In patients with resectable gastric/gastroesophageal junction (GEJ)
adenocarcinoma, surgery plus perioperative platinum-based chemotherapy is the standard …
adenocarcinoma, surgery plus perioperative platinum-based chemotherapy is the standard …
Mapping the genomic diaspora of gastric cancer
Gastric cancer (GC) is a leading contributor to global cancer incidence and mortality.
Pioneering genomic studies, focusing largely on primary GCs, revealed driver alterations in …
Pioneering genomic studies, focusing largely on primary GCs, revealed driver alterations in …
Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer
F Pietrantonio, R Miceli, A Raimondi… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE In the CLASSIC and MAGIC trials, microsatellite instability (MSI)–high status was
a favorable prognostic and potential negative predictive factor for neoadjuvant/adjuvant …
a favorable prognostic and potential negative predictive factor for neoadjuvant/adjuvant …
[HTML][HTML] Biomarkers of gastric cancer: Current topics and future perspective
T Matsuoka, M Yashiro - World journal of gastroenterology, 2018 - ncbi.nlm.nih.gov
Gastric cancer (GC) is one of the most prevalent malignant types in the world and an
aggressive disease with a poor 5-year survival. This cancer is biologically and genetically …
aggressive disease with a poor 5-year survival. This cancer is biologically and genetically …
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
FH Wang, L Shen, J Li, ZW Zhou, H Liang… - Cancer …, 2019 - Springer
China is one of the countries with the highest incidence of gastric cancer. There are
differences in epidemiological characteristics, clinicopathological features, tumor biological …
differences in epidemiological characteristics, clinicopathological features, tumor biological …
[HTML][HTML] Microsatellite instability in Gastric Cancer: Between lights and shadows
Gastric cancer (GC) represents an important contributor to the global burden of cancer,
being one of the most common and deadly malignancies worldwide. According to TCGA and …
being one of the most common and deadly malignancies worldwide. According to TCGA and …